The research will aid basic understanding of brain development, and also help understanding cellular origins of brain disorders caused by errors in development.
Geneticists discovered that mTORC3 aids cancers' resistance to rapamycin and related drugs, offering the promise of new drug therapies to treat cancers.
Read the latest on the roots of mixed phenotype acute leukemia (MPAL), including how the findings might affect treatment of patients with the high-risk cancer.
CBS Sports HQ will partner with
St. Jude to support Childhood Cancer Awareness Month by streaming a live Fantasy Football Telethon on Labor Day.
Flu infections pose a significant risk to infants. Read about the T cells the immune system relies on to repair lung damage in infants infected with influenza.
Read about what happened when researchers looked beyond mutations to understand the developmental origins and vulnerabilities of rhabdomyosarcoma.
St. Jude is the first and only NCI-designated Comprehensive Cancer Center that is devoted solely to children.
Ahead of the 2018 FedExCup Playoffs, defending FedExCup champion Justin Thomas completed against NBC’s The Tonight Show Starring Jimmy Fallon in a friendly golf game, with FedEx donating $1 million to
St. Jude in honor of the winner.
St. Jude investigators find that cognitive impairment and physical performance limitations are strong predictors of non-independence in survivors.
Financial hardship is widespread among childhood cancer survivors, reducing their quality of life and leaving them at risk for depression, other problems.
Researchers identify mutations responsible for an inherited bone marrow disorder and evidence some affected patients may regain normal immune function without treatment.
The partnership with Institute for Health Metrics and Evaluation will provide more accurate estimates of the global burden of cancer among children.
Metabolic activity in immune cells influences the fate of developing T cells, including a protein complex that plays a decisive role.
Surveys from the Childhood Cancer Survivor Study found that a surprisingly high number of survivors showed a lack of concern for their future well-being.
Researchers have applied a new way to trigger medulloblastoma in neural cells that will lead to the ability to test a promising class of anti-tumor drugs.
Under Downing’s leadership,
St. Jude has increased employee feedback channels and forums, resulting in more innovation and connectivity across the Memphis-based campus.
Check out a new algorithm that is available at no cost to help researchers get the most out of single-cell RNA sequencing technology.
Joint statement empowers parents, young adults and physicians to act to increase vaccination rates and screenings to eliminate HPV-related cancers
Study found ethanol-lock therapy failed to prevent new or recurring infections in cancer patients with central venous catheters and led to more complications.
St. Jude experts share pediatric oncology and survivorship research at the annual meeting of the American Society of Clinical Oncology.
Read about the algorithm that helped researchers uncover hidden drivers of immune regulation and production of anti-tumor T cells.
Hospital invests more than $100 million to improve childhood cancer survival rates worldwide.
For a subset of the youngest patients with the brain tumor medulloblastoma, less aggressive therapy was associated with better long-term survival.
The protein called BOK offers another target for drugs to selectively trigger apoptosis.
St. Jude is partnering with WHO to develop strategies that strengthen the global resources, organization and planning needed to identify and treat pediatric cancer.
Researchers created the first genetic screening guidelines for medulloblastoma patients after identifying gene variations that make carriers susceptible.
Using combination therapy for flu, a new class of drug offers potential for multi-drug therapy and possibly improved influenza-fighting drugs.
A family’s history of childhood leukemia leads to the discovery of a fourth gene (IKZF1) that predisposes carriers to pediatric acute lymphoblastic leukemia.
Explore research and resources by
St. Jude at the annual meeting of the American Association for Cancer Research (AACR) in Chicago.
St. Jude to offer next-generation sequencing data and analysis tools to accelerate research and cures for life-threatening pediatric diseases.